Treatment of Paget's disease of bone with single dose intravenous pamidronate (Q33565715)

28 July 2017

Treatment of Paget's disease of bone with single dose intravenous pamidronate (English)

1 reference

28 July 2017

Paget's disease of bone

1 reference

Watts RA

1

1 reference

28 July 2017

Skingle SJ

2

1 reference

28 July 2017

Bhambhani MM

3

1 reference

28 July 2017

Pountain G

4

1 reference

28 July 2017

Crisp AJ

5

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 August 1993

1 reference

Annals of the Rheumatic Diseases

28 July 2017

1 reference

28 July 2017

52

1 reference

28 July 2017

8

1 reference

28 July 2017

616-618

1 reference

Structure-activity relationships of various bisphosphonates

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005123

Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005123

Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005123

Absorption of oral diphosphonate in normal subjects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005123

Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005123

Clinical experience with pamidronate in the treatment of Paget's disease of bone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1005123

Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy

21 June 2018

1 reference

12 December 2020

A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone

1 reference

12 December 2020

Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate)

1 reference

12 December 2020

Intravenous aminopropylidene bisphosphonate (APD) in the treatment of Paget's bone disease

1 reference

12 December 2020

Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD)

1 reference

12 December 2020

Paget's disease of bone treated in five days with AHPrBP (APD) per Os

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.52.8.616

1 reference

28 July 2017

1 reference

28 July 2017

1 reference